双能X线吸收法测定的低瘦体重定义肌少症与类风湿关节炎共病的关联:全国性横断面健康检查结果
该研究从2008-2011年韩国国民健康与营养调查数据库中按1:5比例选取400例类风湿关节炎(RA)患者和2000例年龄性别匹配的非RA对照,以四肢骨骼肌量定义肌少症。RA患者中肌少症与肥胖、血脂异常、慢性阻塞性肺疾病及乙肝既往感染相关,且仅RA合并肌少症亚组与多种共病、心血管疾病及抑郁相关。作者认为肌少症与RA相关共病显著相关,应特别关注肌少症RA患者的共病。
要点
- RA患者中肌少症患病率为20.5%,非RA组为19.3%。
- RA患者中肌少症与肥胖(OR 2.61)、血脂异常(OR 3.09)、COPD(OR 18.77)及乙肝既往感染(OR 8.69)相关。
- 仅RA合并肌少症亚组与共病、心血管疾病及抑郁相关,健康相关行为在有无肌少症患者间相当。
核心结论
- 在RA患者中,肌少症与肥胖、血脂异常、COPD及乙肝既往感染相关。
- 仅RA合并肌少症亚组与多种共病、心血管疾病及抑郁相关,提示肌少症与RA相关共病显著相关。
- 作者认为应特别关注肌少症RA患者的共病。
研究设计与样本
- 全国性横断面研究,从2008-2011年韩国国民健康与营养调查数据库中按1:5比例选取RA患者和年龄性别匹配的非RA对照。
- 共纳入400例RA患者和2000例非RA对照,平均年龄57.4岁,女性占79.6%。
- 肌少症以四肢骨骼肌量定义,采用加权logistic回归估计OR和95%CI,调整年龄、性别和收入。
主要发现
- RA组肌少症患病率为20.5%,非RA组为19.3%。
- RA患者中,肌少症与肥胖(OR 2.61,95%CI 1.42-4.83)、血脂异常(OR 3.09,95%CI 1.37-6.99)、糖尿病(OR 2.07,95%CI 0.99-4.33)、COPD(OR 18.77,95%CI 2.40-146.55)及乙肝既往感染(OR 8.69,95%CI 1.15-65.58)相关。
- 与无RA无肌少症亚组相比,仅RA合并肌少症亚组与上述共病、心血管疾病及抑郁相关。
- 有无肌少症的RA患者之间健康相关行为(运动、吸烟、饮酒、饮食)相当。
关键数值与推荐
- 肌少症定义为四肢骨骼肌量低。
- RA患者中肌少症与肥胖的OR为2.61(95%CI 1.42-4.83)。
- RA患者中肌少症与血脂异常的OR为3.09(95%CI 1.37-6.99)。
- RA患者中肌少症与COPD的OR为18.77(95%CI 2.40-146.55)。
- RA患者中肌少症与乙肝既往感染的OR为8.69(95%CI 1.15-65.58)。
临床怎么用
- 原文未据此给出推荐。
- 作者认为应特别关注肌少症RA患者的共病。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To examine the association between sarcopenia and comorbidities among patients with rheumatoid arthritis (RA). METHODS: We selected RA patients and age- and sex-matched non-RA controls at a 1:5 ratio from 2008-2011 Korea National Health and Nutrition Examination Survey database. Sarcopenia was defined by appendicular skeletal muscle mass. After investigating associations between sarcopenia and individual comorbidities among RA patients, we performed a stratified analysis comparing three subgroups (RA/sarcopenia, RA/non-sarcopenia, non-RA/sarcopenia) versus a non-RA/non-sarcopenia subgroup to evaluate interactive as well as independent effects of sarcopenia and RA on comorbidities. Health-related behaviors (exercise, smoking, drinking, and diet) were also examined. The weighted logistic regression estimated odds ratios (ORs) and 95% confidence intervals (CIs) adjusting for age, sex, and income. RESULTS: We included 400 RA patients and 2,000 non-RA controls (mean age 57.4 years, 79.6% female). Sarcopenia was observed in 20.5% of RA and 19.3% of non-RA group. Among RA patients, sarcopenia was associated with obesity (OR 2.61, 95% CI 1.42-4.83), dyslipidemia (3.09, 1.37-6.99), diabetes (2.07, 0.99-4.33), chronic obstructive pulmonary disease (18.77, 2.40-146.55), and hepatitis B ever-infection (8.69, 1.15-65.58). Among three stratified subgroups, only a RA/sarcopenia subgroup was associated with such comorbidities, cardiovascular diseases, and depression compared to a non-RA/non-sarcopenia subgroup. Health-related behaviors were comparable between patients with and without sarcopenia. CONCLUSIONS: In this nation-wide cross-sectional study, a wide spectrum of comorbidities were preferentially found among RA patients with sarcopenia than without, suggesting that sarcopenia is significantly associated with RA-related comorbidities. Particular attention should be paid to comorbidities of sarcopenic RA patients.
引用
- Shin A, Choi SR, Han M, et al. Association between sarcopenia defined as low lean mass by dual-energy X-ray absorptiometry and comorbidities of rheumatoid arthritis: Results of a nationwide cross-sectional health examination. Semin Arthritis Rheum. 2022. PMID: 36099743. doi:10.1016/j.semarthrit.2022.152090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。